Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis

Int J Antimicrob Agents. 2006 Apr;27(4):300-2. doi: 10.1016/j.ijantimicag.2005.11.008. Epub 2006 Mar 9.

Abstract

We report the first linezolid-resistant Staphylococcus aureus strain isolated in Brazil. The strain was isolated from a 10-year-old female patient with cystic fibrosis (CF) who received repeated and prolonged courses of low-dose linezolid. The strain belonged to the Brazilian endemic methicillin-resistant S. aureus clone, and the G2576U mutation was identified in domain V of the 23S rRNA. Detection of this mechanism of resistance in a CF patient is very worrisome, as these patients may become a reservoir for further dissemination of resistant strains. Our findings emphasise the importance of optimal dosage of linezolid to prevent the emergence of resistance.

Publication types

  • Case Reports

MeSH terms

  • Acetamides / administration & dosage
  • Acetamides / pharmacology*
  • Acetamides / therapeutic use
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Brazil
  • Child
  • Cystic Fibrosis / complications*
  • Drug Resistance, Bacterial / genetics*
  • Female
  • Humans
  • Linezolid
  • Methicillin Resistance
  • Oxazolidinones / administration & dosage
  • Oxazolidinones / pharmacology*
  • Oxazolidinones / therapeutic use
  • Point Mutation
  • RNA, Ribosomal, 23S / genetics
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / isolation & purification

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Oxazolidinones
  • RNA, Ribosomal, 23S
  • Linezolid